Pharmacokinetics of amoxicillin in maternal, umbilical cord, and neonatal sera

Antimicrobial Agents and Chemotherapy

Volumn 53, Issue 4, 2009, Pages 1574-1580

  Muller, Anouk E ^a,e   Oostvogel, Paul M ^a   DeJongh, Joost ^b,c   Mouton, Johan W ^d   Steegers, Eric A P ^e   Joep Dorr P ^a   Danhof, Meindert ^b,c   Voskuyl, Rob A ^c  

^a MEDICAL CENTER HAAGLANDEN   (Netherlands)

^b LAP and P Consultants BV   (Netherlands)

^c LEIDEN UNIVERSITY   (Netherlands)

^d CANISIUS WILHELMINA HOSPITAL   (Netherlands)

^e ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID;

ADULT; ARTERIAL BLOOD; ARTICLE; BLOOD SAMPLING; COMPARTMENT MODEL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; FEMALE; HUMAN; MATERNAL PLASMA; MINIMUM INHIBITORY CONCENTRATION; NEWBORN; NEWBORN PERIOD; NONLINEAR SYSTEM; PHARMACOKINETICS; PRIORITY JOURNAL; STREPTOCOCCUS INFECTION; UMBILICAL CORD BLOOD; VENOUS BLOOD;

ADULT; AMOXICILLIN; ANTI-BACTERIAL AGENTS; FEMALE; HUMANS; INFANT, NEWBORN; MODELS, BIOLOGICAL; PREGNANCY; UMBILICAL CORD;

EID: 65649099382     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00119-08     Document Type: Article

References (12)

1. Adam, D., I. de Visser, and F. Koeppe. 1982. Pharmacokinetics of amoxicillin and ciavulanic acid administered alone and in combination. Antimicrob. Agents Chemother. 22:353-357. (Pubitemid 13241690)
2. Bloom, S. L., S. M. Cox, R. E. Bawdon, and L. C. Gilstrap. 1996. Ampicillin for neonatal group B streptococcal prophylaxis: how rapidly can bactericidal concentrations be achieved? Am. J. Obstet. Gynecol. 175:974-976. (Pubitemid 26357965)
3. Bonate, P. L. 2005. Recommended reading in population pharmacokinetic pharmacodynamics. AAPS J. 7:E363-E373. (Pubitemid 43078598)
4. Colombo, D. F., J. L. Lew, C. A. Pedersen, J. R. Johnson, and P. Fan-Havard. 2006. Optimal timing of ampicillin administration to pregnant women for establishing bactericidal levels in the prophylaxis of group B streptococcus. Am. J. Obstet. Gynecol. 194:466-470. (Pubitemid 43183702)
5. EUCAST. Antimicrobial wild type distributions of microorganisms. EU-CAST, Basel, Switzerland. http://217.70.33.99/Eucast2/.
6. (D) in vivo by positron emission tomography. Mol. Imaging Biol. 7:411-421. (Pubitemid 44193406)
7. Müller, A. E., J. Dejongh, P. M. Oostvogel, R. A. Voskuyl, P. J. Dorr, M. Danhof, and J. W. Mouton. 2008. Amoxicillin pharmacokinetics in pregnant women with preterm premature rupture of the membranes. Am. J. Obstet. Gynecol. 198:108.el-108.e6.
8. Reed, M. D. 1996. Clinical pharmacokinetics of amoxicillin and clavulanate. Pediatr. Infect. Dis. J. 15:949-954. (Pubitemid 26339619)
9. Schoemaker, R. C, and A. F. Cohen. 1996. Estimating impossible curves using NONMEM. Br. J. Clin. Pharmacol. 42:283-290. (Pubitemid 26284415)
10. Schräg, S., R. Gorwitz, K. Fultz-Butts, and A. Schuchat. 2002. Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC. MMWR Recomm. Rep. 51(RR-11):l-22.
11. Sheiner, B. L., and S. L. Beal. 1981. Evaluation of methods for estimating population pharmacokinetic parameters. II. Biexponential model and experimental pharmacokinetic data. J. Pharmacokinet. Biopharm. 9:635-651. (Pubitemid 12210179)
12. Weber, D. J., N. E. Tolkoff-Rubin, and R. H. Rubin. 1984. Amoxicillin and potassium clavulanate: an antibiotic combination. Mechanism of action, pharmacokinetics, antimicrobial spectrum, clinical efficacy and adverse effects. Pharmacotherapy 4:122-136. (Pubitemid 14075132)